Neuronal death in Parkinson's disease (PD) is driven by mitochondrial dysfunction, oxidative stress, endoplasmic reticulum (ER) stress, and α-synuclein aggregation. This study investigates the neuroprotective potential of 18β-Glycyrrhetinic acid (18βGA) in a chronic MPTP/probenecid (MPTP/p)-induced mouse model of PD. Behavioural assessments demonstrates that 18βGA significantly ameliorated MPTP/p-induced motor impairments. Biochemical analyses revealed that 18βGA markedly restored the activities of electron transport chain complexes I-V, reduced intracellular reactive oxygen species (ROS) accumulation, and preserved mitochondrial membrane potential disrupted by MPTP/p exposure. Enzyme-linked immunosorbent assay (ELISA) further showed that 18βGA reduced pro-inflammatory cytokine levels (TNF-α and IL-1β), restored antioxidant enzyme activities (superoxide dismutase and glutathione peroxidase), and decreased malondialdehyde (MDA) levels. Immunoblotting and Immunofluorescence analysis revealed preservation of tyrosine hydroxylase-positive dopaminergic neurons, accompanied by reduced α-synuclein accumulation and decreased BiP (GRP78) expression in the substantia nigra. Western blot analyses confirmed downregulation of ER stress markers (BiP and CHOP), inflammatory mediators (TNF-α and NF-κB), and pro-apoptotic proteins (Bax and cleaved caspase-3), along with upregulation of the anti-apoptotic protein BCL2 and activation of the PI3K/AKT signalling pathway following 18βGA treatment. Collectively, these findings demonstrate that 18βGA exerts robust neuroprotective effects by attenuating mitochondrial dysfunction, oxidative stress, ER stress, inflammation, and apoptosis, highlighting its potential as a promising therapeutic candidate for Parkinson's disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13205-026-04757-4.
18β-Glycyrrhetinic acid attenuates endoplasmic reticulum stress and neuroinflammation via the PI3K/AKT-dependent pathway in MPTP/p-induced Parkinson's disease mouse model.
18β-甘草次酸通过 PI3K/AKT 依赖性通路减轻 MPTP/p 诱导的帕金森病小鼠模型中的内质网应激和神经炎症。
阅读:6
作者:
| 期刊: | 3 Biotech | 影响因子: | 2.900 |
| 时间: | 2026 | 起止号: | 2026 Apr;16(4):138 |
| doi: | 10.1007/s13205-026-04757-4 | 种属: | Mouse |
| 靶点: | AKT | 研究方向: | 信号转导、神经科学、炎症/感染 |
| 疾病类型: | 帕金森、神经炎症 | 信号通路: | PI3K/Akt |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
